National Academy of Medicine

Strengthening Mechanisms to Prioritize, Coordinate, Finance, and Execute R&D to Meet Health Needs in Developing Countries

By Peter Hotez, Rachel Cohen, Carol Mimura, Tadataka Yamada, Stephen L. Hoffman, Deepali M. Patel
January 16, 2013 | Discussion Paper

In response to issues raised in the report of the World Health Organization (WHO)-affiliated Consultative Expert Working Group (CEWG) on research and development (R&D) financing and coordination and the desire of the U.S. government to obtain a wide range of nongovernmental perspectives on the funding and coordination of the global health research enterprise, several members of the IOM Global Health Interest Group and other experts combined efforts to produce an IOM discussion paper to capture their views on approaches to research priority-setting, the leading gaps in global health R&D, R&D planning and costing, the private-sector role in global health R&D, the creation of effective global health research networks, the building of R&D capacity in developing countries, innovations in financing the global health R&D enterprise, and principles of global health R&D management.

Note

Disclaimer: The views expressed in this paper are those of the authors and not necessarily of the authors’ organizations, the National Academy of Medicine (NAM), or the National Academies of Sciences, Engineering, and Medicine (the National Academies). The paper is intended to help inform and stimulate discussion. It is not a report of the NAM or the National Academies. Copyright by the National Academy of Sciences. All rights reserved.